Coinbase CEO's anti-aging startup NewLimit is raising $435 million, tripling its valuation
Culture Index
Score Breakdown
Relevance
14/25
Freshness
25/25
Authority
18/20
Brand Signal
6/15
Depth
2/15
5-Axis Cultural Radar
The South San Francisco biotech plans to begin its first human trial of a liver cell-reprogramming therapy next year
